Sera Prognostics (SERA) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
4 Jun, 2026Opening remarks and agenda
Meeting called to order at 9:00 A.M. Mountain Time and held virtually to improve shareholder access.
Agenda and rules of conduct were made available to all participants, with opportunities for questions on proposals.
Board and executive committee updates
Current directors and management introduced, including nominees for re-election and key executives.
Biographies of director nominees provided in the proxy statement.
Corporate governance
Quorum established with 67.48% of outstanding voting stock represented.
Meeting held pursuant to notice mailed to stockholders of record.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Sera Prognostics
- Commercial focus accelerates after PRIME results, with reimbursement and awareness as top priorities.SERA
Jefferies Global Healthcare Conference 20263 Jun 2026 - Director nominee resignation leads to a reduced board; proxy votes for him will not be counted.SERA
Proxy filing1 Jun 2026 - Strong trial results drive rapid state and payer engagement for preterm birth screening.SERA
TD Cowen 46th Annual Health Care Conference18 May 2026 - PreTRM enables early, accurate preterm birth risk prediction, improving outcomes and reducing costs.SERA
Corporate presentation8 May 2026 - Net loss of $8.4M and $14,000 revenue, with cash runway extended through 2029.SERA
Q1 20267 May 2026 - PreTRM enables early, accurate preterm birth risk prediction, improving neonatal outcomes and reducing costs.SERA
Corporate presentation6 May 2026 - Director elections, auditor ratification, and ESG priorities highlight this year's proxy.SERA
Proxy filing24 Apr 2026 - Vote on director elections and auditor ratification at the June 2026 virtual annual meeting.SERA
Proxy filing24 Apr 2026 - PRIME study validated efficacy, commercial expansion advanced, and cash runway secured.SERA
Q4 202518 Mar 2026